These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 4472584

  • 1. Reduction of carcinogen-induced mammary cancer incidence in rats by early treatment with hormones or drugs.
    Kledzik GS, Bradley CJ, Meites J.
    Cancer Res; 1974 Nov; 34(11):2953-6. PubMed ID: 4472584
    [No Abstract] [Full Text] [Related]

  • 2. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
    Yuri T, Tsukamoto R, Uehara N, Matsuoka Y, Tsubura A.
    In Vivo; 2006 Nov; 20(6B):829-36. PubMed ID: 17203775
    [Abstract] [Full Text] [Related]

  • 3. Effects of neonatally administered sex steroids on 7,12-dimethylbenz(a)anthracene-induced mammary neoplasia in rats.
    Shellabarger CJ, Soo VA.
    Cancer Res; 1973 Jul; 33(7):1567-9. PubMed ID: 4737228
    [No Abstract] [Full Text] [Related]

  • 4. Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine.
    Lemon HM.
    Cancer Res; 1975 May; 35(5):1341-53. PubMed ID: 123480
    [Abstract] [Full Text] [Related]

  • 5. Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Teller MN, Kaufman RJ, Bowie M, Stock CC.
    Cancer Res; 1969 Feb; 29(2):349-52. PubMed ID: 5765416
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy experiments on autochthonic mammary carcinoma in rats].
    Fretz J, Rohde W, Schmähl D, Thomas C.
    Arzneimittelforschung; 1969 Aug; 19(8):1291-5. PubMed ID: 5820295
    [No Abstract] [Full Text] [Related]

  • 7. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM, Christov K.
    Anticancer Res; 2003 Aug; 23(4):3207-13. PubMed ID: 12931682
    [Abstract] [Full Text] [Related]

  • 8. N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats.
    Tsukamoto R, Mikami T, Miki K, Uehara N, Yuri T, Matsuoka Y, Okazaki K, Tsubura A.
    Oncol Rep; 2007 Aug; 18(2):337-42. PubMed ID: 17611653
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
    Kang JS, Kim S, Che JH, Nam KT, Kim DJ, Jang DD, Yang KH.
    Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
    [Abstract] [Full Text] [Related]

  • 10. Effect of the antiestrogen C1628 on the growth of rat mammary tumors.
    DeSombre ER, Arbogast LY.
    Cancer Res; 1974 Aug; 34(8):1971-6. PubMed ID: 4842251
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced regression of DMBA-induced mammary cancers in rats by combination of ergocornine with ovariectomy or high doses of estrogen.
    Quadri SK, Kledzik GS, Meites J.
    Cancer Res; 1974 Mar; 34(3):499-501. PubMed ID: 4812257
    [No Abstract] [Full Text] [Related]

  • 12. Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17 beta level in rats.
    Nagasawa H, Yanai R, Shodono M, Nakamura T, Tanabe Y.
    Cancer Res; 1974 Oct; 34(10):2643-6. PubMed ID: 4413074
    [No Abstract] [Full Text] [Related]

  • 13. Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823).
    Shimkin MB, Gropper L, Thatcher D, Gruenstein M.
    Cancer Res; 1967 Nov; 27(11 Pt 2):1284-8. PubMed ID: 5630409
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition by progesterone of radiation-estrogen-induced mammary cancer in the rat.
    Segaloff A.
    Cancer Res; 1973 May; 33(5):1136-7. PubMed ID: 4703122
    [No Abstract] [Full Text] [Related]

  • 15. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW, Aylsworth CF, Van Vugt DA, Meites J.
    Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of estrogen-dependent rat mammary cancer by EMD 16-795, a new synthetic anti-estrogen.
    Schulz KD, Wüstenberg B.
    Horm Metab Res; 1971 Jul; 3(4):295-6. PubMed ID: 5129993
    [No Abstract] [Full Text] [Related]

  • 17. Relation of prolactin and estrogen to mammary tumorigenesis in the rat.
    Meites J.
    J Natl Cancer Inst; 1972 Apr; 48(4):1217-24. PubMed ID: 5023679
    [No Abstract] [Full Text] [Related]

  • 18. Mammary adenocarcinoma induced in organ culture by 7,12-dimethylbenz(a)anthracene.
    Dao TL, Sinha D.
    J Natl Cancer Inst; 1972 Aug; 49(2):591-3. PubMed ID: 5076832
    [No Abstract] [Full Text] [Related]

  • 19. Effects of a hypothalamic estrogen implant on growth of carcinogen-induced mammary tumors in rats.
    Nagasawa H, Meites J.
    Cancer Res; 1970 May; 30(5):1327-9. PubMed ID: 5426935
    [No Abstract] [Full Text] [Related]

  • 20. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.